Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,415 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    Strategies For Parameter Patents In The United States

    Finnegan attorney Chiaki Kobayashi authored an article titled, "Strategies for Parameter Patents in the United States," for the January 2023 issue of Intellectual Property Management...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    "Substantially Equivalent" Method Of Obtaining Dissolution Profile Meets Written Description Requirement

    In Nalpropion Pharmaceuticals v. Actavis Laboratories FL, Inc., No. 2018-1221, the Court addressed whether a particular claimed dissolution profile had the requisite written description support.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Success On The Merits Not Necessary To Be Prevailing Party Under Section 285

    In Raniere v. Microsoft Corp., the Federal Circuit analyzed what it meant to be a prevailing party under 35 U.S.C. § 285.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Successor-In-Interest Can Challenge Decisions By The Board And Assert Their Interests

    In Mojave Desert Holdings, LLC, v Crocs, Inc., No. 2020-1167 (Fed. Cir. Feb. 11, 2021), the Federal Circuit held that a successor-in-interest is a real party-in-interest to an inter partes...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Supplemental Expert Reports Cannot Be Submitted Via A Notice Of Reliance

    The TTAB recently clarified its procedures for making evidence of record through notices of reliance.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    The 3D Bioprinting Patent Landscape Takes Shape As IP Leaders Emerge

    3D bioprinting, a type of 3D printing, is a rapidly growing field with more players entering the arena every day. Complementing this growth, 3D bioprinting patent filings are trending upward. 3D bioprinting is a hot area for intellectual property.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    The Chemical And Pharmaceutical Innovation Report 2013

    Finnegan is pleased to release The Chemical and Pharmaceutical Innovation Report 2013.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    The Computer-Readable Medium Claim: The Best Of The Apparatus And Method Worlds After Williamson

    The recent en banc Federal Circuit decision in Williamson v. Citrix Online, LLC could change how courts interpret an entire class of patent claim features.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    The Federal Circuit Adopts A Liberal, Notice-Based Interpretation Of The Relation Back Doctrine Under Rule 15(c)

    In Anza Technology, Inc. v. Mushkin Inc., No. 2019-1045 (Fed. Cir. Aug. 16, 2019), the Court assessed whether claims in an amended complaint could relate back to the filing date of the original
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    The Federal Circuit Cools On The Board's Claim Construction Of Vivant's HVAC Patents

    In Vivint Inc. v. Alarm.com Inc., No. 17-2218 (December 20, 2018), the Federal Circuit in a non-precedential opinion affirmed the Board's invalidation of some of Vivant's patent claims
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    The Seventh Amendment Does Not Bar Pre-Verdict Supplemental Damages

    In Bayer Healthcare LLC v. Baxalta Inc., No. 19-2418 (Fed. Cir. Mar. 1, 2021), the Federal Circuit reviewed many issues on appeal, including Baxalta's Seventh Amendment challenge.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Third Central Division Of The Unified Patent Court To Be Established In Milan

    As reported earlier this year (see our blog post), it had long remained unclear where the third seat of the Central Division will be established after the United Kingdom decided to leave the European Union and the Unified Patent Court (UPC) system.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Top Five Provisions In The PATENT Act Impacting AIA Post-Grant Proceedings

    The burden to show that the substitute claim is unpatentable would be a preponderance of the evidence.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Trade Secrets: Protection And Remedies

    Corporate Practice Series Portfolio No. 43–3rd, Trade Secrets: Protection and Remedies is a ten chapter portfolio that examines the public policy of protecting trade secrets...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Trademarks – What Game Developers Should Know

    Intellectual property is critical to the gaming industry. From independently produced mobile applications to big AAA titles, the market is flooded with more and more options for gamers every day.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Trading Screen Displaying "Profits & Loss" Data Not Eligible For Patenting

    In Trading Technologies International, Inc. v. IBG LLC, No. 2017-2323 (Fed. Cir. April 30, 2019), the Federal Circuit affirmed the Board's decision,
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Treatment Claims Reciting Specific And Unconventional Dosage Not Patent Ineligible

    In Natural Alternatives Int'l v. Creative Compounds, LLC, No. 2018-1295 (Fed. Cir. Mar. 15, 2019), the Federal Circuit reversed the district court's decision granting a motion for judgment on the
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Trenton Ward And Rachel Emsley On Oil States Energy Services, LLC v. Greene's Energy Group, LLC And SAS Institute v. Iancu

    On April 24, 2018, the Supreme Court handed down two opinions in cases related to IPR. In a 7-2 decision, the Court upheld the constitutionality of IPRs in Oil States Energy Services, LLC v. Greene's Energy Group, LLC.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Podcast

    Update On Apple Inc. v. Fintiv Inc. (Podcast)

    In this podcast, Finnegan partners Jeff Totten and Tim McAnulty provide an update on Apple v. Fintiv.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Update To The Purple Book In Recent COVID-19 Stimulus Bill And Implications For BPCIA Litigation

    On December 21, 2020, Congress passed a second COVID-19 stimulus bill. Buried among the 5500 pages of the 900 billion dollar relief package was legislation updating procedures ...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Showing 941–960 of 4415 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics